Background Investigation Methods, Corporate Intelligence & Due Diligence, e-Discovery Techniques, Investigation & Intelligence Feeds, Judgment Enforcement, Legal Enforcement Cases, Legal Ethics & Intelligence, Legal Technology & Intelligence, Witness Credibility Analysis

Vera Therapeutics Submits BLA to FDA for Atacicept Fusion Protein

Posted by author-avatar
0
Test Logo Transparent

On November 7, Vera Therapeutics announced that it submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) through the Accelerated Approval Program for atacicept for the treatment of adults with immunoglobulin A nephropathy (IgAN), a progressive autoimmune disease of the kidney. …
By: Goodwin

Newer
White House Announces Multiple Trade Deals Following President Trump’s Tour of Asia
Back to list
Older Legal Ethics Roundup: Judge Resigns In Protest, More AI Sanctions, Bar Complaint Against Halligan, SCOTUS Ethics Code Turns 2 & More

Leave a Reply

Your email address will not be published. Required fields are marked *